Tumores mamarios en perras y gatas

Referencias bibliográficas

• 1.Anadol, E., Yar Saglam, A. S., Gultiken, N., et al. (2017) Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade. Acta veterinaria Hungarica 65, 382-393
• 2.Arenas, C., Pena, L., Granados-Soler, J. L., et al. (2016) Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study. The Veterinary record 179, 125
• 3.Bearss, J. J., Schulman, F. Y., Carter, D. (2012) Histologic, immunohistochemical, and clinical features of 27 mammary tumors in 18 male dogs. Veterinary pathology 49, 602-607
• 4.Borrego, J. F., Cartagena, J. C., Engel, J. (2009) Treatment of feline mammary tumours using chemotherapy, surgery and a COX2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002-2007)*. Veterinary and comparative oncology 7, 213-221
• 5.Clemente, M., De Andres, P. J., Pena, L., et al. (2009) Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy. The Veterinary record 165, 78-81
• 6.Clemente, M., Sanchez-Archidona, A. R., Sardon, D., et al. (2013) Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer. Veterinary journal (London, England : 1997) 197, 427-432
• 7.Cunha, S. C., Corgozinho, K. B., Souza, H. J., et al. (2015) Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy. Journal of feline medicine and surgery 17, 1000-1004
• 8. de Andres, P. J., Jimenez, M. A., Clemente, M., et al. (2004) Effects of Aglepristone administered before surgical treatment in dogs with spontaneous mammary tumours. Proceedings from 16 th ECVIM-CA Congress, 14-16 sept 2006. Amsterdam, Netherlands. p 179
• 9. de Campos, C. B., Lavalle, G. E., Monteiro, L. N., et al. (2018) Adjuvant Thalidomide and Metronomic Chemotherapy for the Treatment of Canine Malignant Mammary Gland Neoplasms. In vivo (Athens, Greece) 32, 1659-1666
• 10.De Campos, C. B., Nunes, F. C., Lavalle, G. E., et al. (2014) Use of surgery and carboplatin in feline malignant mammary gland neoplasms with advanced clinical staging. In vivo (Athens, Greece) 28, 863-866
• 11.de M. Souza, C. H., Toledo-Piza, E., Amorin, R., et al. (2009) Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. The Canadian veterinary journal = La revue veterinaire canadienne 50, 506-510
• 12.Dorn, C. R., Taylor, D. O., Schneider, R., et al. (1968) Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 40, 307-318
• 13.Fossum, T. W. (2008) Cirugía del aparato reproductor de la hembra: Enfermedades específicas: Neoplasia Mamaria. In: Cirugía en Pequeños Animales. Theresa Welch Fossum. 3ª edn. pp 729-735
• 14.Gaspar, T. B., Henriques, J., Marconato, L., et al. (2018) The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field. Veterinary and comparative oncology 16, 2-11
• 15.Gemignani, F., Mayhew, P. D., Giuffrida, M. A., et al. (2018) Association of surgical approach with complication rate, progressionfree survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991-2014). Journal of the American Veterinary Medical Association 252, 1393-1402
• 16.Goldschmidt, M., Pena, L., Rasotto, R., et al. (2011) Classification and grading of canine mammary tumors. Veterinary pathology 48, 117-131
• 17.Guil-Luna, S., Millan, Y., De Andres, J., et al. (2017) Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas. Veterinary and comparative oncology 15, 391-399
• 18.Harper, A., Blackwood, L. (2017) Toxicity and response in cats with neoplasia treated with toceranib phosphate. Journal of feline medicine and surgery 19, 619-623
• 19.Hayes, H. M., Jr., Milne, K. L., Mandell, C. P. (1981) Epidemiological features of feline mammary carcinoma. The Veterinary record 108, 476-479
• 20.Hermo, G. A., Turic, E., Angelico, D., et al. (2011) Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade. Journal of the American Animal Hospital Association 47, 21-27
• 21.Jeglum, K. A., deGuzman, E., Young, K. M. (1985) Chemotherapy of advanced mammary adenocarcinoma in 14 cats. Journal of the American Veterinary Medical Association 187, 157-160.
• 22.Karayannopoulou, M., Kaldrymidou, E., Constantinidis, T. C., et al. (2001) Adjuvant post-operative chemotherapy in bitches with mammary cancer. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 48, 85-96.
• 23.Kaszak, I., Ruszczak, A., Kanafa, S., et al. (2018) Current biomarkers of canine mammary tumors. Acta veterinaria Scandinavica 60, 66
• 24.Komazawa, S., Sakai, H., Itoh, Y., et al. (2016) Canine tumor development and crude incidence of tumors by breed based on domestic dogs in Gifu prefecture. The Journal of veterinary medical science 78, 1269-1275.
• 25.Kristiansen, V. M., Nodtvedt, A., Breen, A. M., et al. (2013) Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial. Journal of veterinary internal medicine 27, 935-942.
• 26.Kristiansen, V. M., Pena, L., Diez Cordova, L., et al. (2016) Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized controlled Trial. Journal of veterinary internal medicine 30, 230-241.
• 27.Lavalle, G. E., De Campos, C. B., Bertagnolli, A. C., et al. (2012) Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors. In vivo (Athens, Greece) 26, 375-379
• 28.Leidinger, E., Hooijberg, E., Sick, K., et al. (2011) Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 39, 198-202
• 29.London, C. A., Hannah, A. L., Zadovoskaya, R., et al. (2003) Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 9, 2755-2768
• 30.MacEwen, E. G., Hayes, A. A., Harvey, H. J., et al. (1984) Prognostic factors for feline mammary tumors. Journal of the American Veterinary Medical Association 185, 201-204
• 31.Marconato, L., Lorenzo, R. M., Abramo, F., et al. (2008) Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. Veterinary and comparative oncology 6, 90-101.
• 32.Marconato, L., Romanelli, G., Stefanello, D., et al. (2009) Prognostic factors for dogs with mammary inflammatory carcinoma:43 cases (2003-2008). Journal of the American Veterinary Medical Association 235, 967-972
• 33.Maues, T., El-Jaick, K. B., Costa, F. B., et al. (2019) Could polymorphisms in ABCB1 gene represent a genetic risk factor for the development of mammary tumors in dogs? Veterinary journal (London, England : 1997) 248, 58-63
• 34.Mauldin, G. N., Matus, R. E., Patnaik, A. K., et al. (1988) Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats. Journal of veterinary internal medicine 2, 60-65
• 35.McNeill, C. J., Sorenmo, K. U., Shofer, F. S., et al. (2009) Evaluation of adjuvant doxorubicin-based chemotherapy for the treatment of feline mammary carcinoma. Journal of veterinary internal medicine 23, 123-129
• 36.Merlo, D. F., Rossi, L., Pellegrino, C., et al. (2008) Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa,Italy. Journal of veterinary internal medicine 22, 976-984
• 37.Misdorp, W. (1988) Canine mammary tumours: protective effect of late ovariectomy and stimulating effect of progestins. The Veterinary quarterly 10, 26-33
• 38.Novosad, C. A., Bergman, P. J., O’Brien, M. G., et al. (2006) Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases. Journal of the American Animal Hospital Association 42, 110-120
• 39.Overley, B., Shofer, F. S., Goldschmidt, M. H., et al. (2005) Association between ovarihysterectomy and feline mammary carcinoma. Journal of veterinary internal medicine 19, 560-563
• 40.Papadopoulou, P. L., Patsikas, M. N., Charitanti, A., et al. (2009) The lymph drainage pattern of the mammary glands in the cat:a lymphographic and computerized tomography lymphographic study. Anatomia, histologia, embryologia 38, 292-299
• 41.Patsikas, M. N., Dessiris, A. (1996a) The lymph drainage of the mammary glands in the bitch: a lymphographic study. Part I: The 1st, 2nd, 4th and 5th mammary glands. Anatomia, histologia, embryologia 25, 131-138
• 42.Patsikas, M. N., Dessiris, A. (1996b) The lymph drainage of the mammary glands in the Bitch: a lymphographic study. Part II:The 3rd mammary gland. Anatomia, histologia, embryologia 25, 139-143
• 43.Patsikas, M. N., Karayannopoulou, M., Kaldrymidoy, E., et al. (2006) The lymph drainage of the neoplastic mammary glands in the bitch: a lymphographic study. Anatomia, histologia, embryologia 35, 228-234
• 44.Pena, L., De Andres, P. J., Clemente, M., et al. (2013) Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.Veterinary pathology 50, 94-105
• 45.Perez-Alenza, M. D., Jimenez, A., Nieto, A. I., et al. (2004) First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases. Breast cancer research : BCR 6, R300-307
• 46.Perez Alenza, D., Rutteman, G. R., Pena, L., et al. (1998) Relation between habitual diet and canine mammary tumors in a casecontrol study. Journal of veterinary internal medicine 12, 132-139
• 47.Perez Alenza, M. D., Tabanera, E., Pena, L. (2001) Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). Journal of the American Veterinary Medical Association 219, 1110-1114
• 48.Poirier, V. J., Hershey, A. E., Burgess, K. E., et al. (2004) Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. Journal of veterinary internal medicine 18, 219-222
• 49.Rossi, F., Sabattini, S., Vascellari, M., et al. (2018) The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma. Veterinary and comparative oncology 16, 497-504
• 50.Saba, C. F., Rogers, K. S., Newman, S. J., et al. (2007) Mammary gland tumors in male dogs. Journal of veterinary internal medicine 21, 1056-1059
• 51.Sarli, G., Preziosi, R., Benazzi, C., et al. (2002) Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 14, 25-34
• 52.Schneider, R., Dorn, C. R., Taylor, D. O. (1969) Factors influencing canine mammary cancer development and postsurgical survival. Journal of the National Cancer Institute 43, 1249-1261
• 53.Simon, D., Schoenrock, D., Baumgartner, W., et al. (2006) Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. Journal of veterinary internal medicine 20, 1184-1190
• 54.Skorupski, K. A., Overley, B., Shofer, F. S., et al. (2005) Clinical characteristics of mammary carcinoma in male cats. Journal of veterinary internal medicine 19, 52-55
• 55.Sonnenschein, E. G., Glickman, L. T., Goldschmidt, M. H., et al. (1991) Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. American journal of epidemiology 133, 694-703
• 56.Sontas, B. H., Turna, O., Ucmak, M., et al. (2008) What is your diagnosis? Feline mammary fibroepithelial hyperplasia. The Journal of small animal practice 49, 545-547
• 57.Sorenmo, K. U., Kristiansen, V. M., Cofone, M. A., et al. (2009) Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Veterinary and comparative oncology 7, 162-172
• 58.Sorenmo, K. U., Rasotto, R., Zappulli, V., et al. (2011) Development, anatomy, histology, lymphatic drainage, clinical features,and cell differentiation markers of canine mammary gland neoplasms. Veterinary pathology 48, 85-97
• 59.Sorenmo, K. U., Worley, D. R., Goldschmidt, M. H. (2012) Tumors of the Mammary Gland. In: Withrow and MacEwen’s Small Animal Clinical Oncology 5th edn. Ed D. M. Vail. pp 538-556
• 60.Stratmann, N., Failing, K., Richter, A., et al. (2008) Mammary tumor recurrence in bitches after regional mastectomy. Veterinary surgery : VS 37, 82-86
• 61.Walker, D. (1968) Mammary adenomas in a male dog--probable oestrogenic neoplasms. The Journal of small animal practice 9, 15-20
• 62.Zappulli, V., Rasotto, R., Caliari, D., et al. (2015) Prognostic evaluation of feline mammary carcinomas: a review of the literature. Veterinary pathology 52, 46-60
• 63.Zapulli, V., Peña, L., Rasotto, R., et al. (2019) Surgical Pathology of Tumors of Domestic Animals Volume 2: Volume 2: Mammary Tumors: Mammary Tumors. Davis Thompson Foundation